Massachusetts Financial Services CO Bluebird Bio, Inc. Transaction History

Massachusetts Financial Services CO

  • $299 Billion
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 13, 2021
SELL
$16.59 - $33.89 $7.45 Million - $15.2 Million
-448,978 Closed
0 $0
Q4 2020

Feb 12, 2021
BUY
$27.5 - $37.92 $2.96 Million - $4.08 Million
107,689 Added 31.55%
448,978 $19.4 Million
Q3 2020

Nov 12, 2020
BUY
$34.44 - $43.75 $11.8 Million - $14.9 Million
341,289 New
341,289 $18.4 Million

Others Institutions Holding BLUE

# of Institutions
32
Shares Held
27M
Call Options Held
191K
Put Options Held
299K
View Full List

About bluebird bio, Inc.

BLUE Quotes by TradingView
  • Ticker BLUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,121,800
  • Market Cap $561M
  • Description
  • bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...
More about BLUE
Track This Portfolio

Track Massachusetts Financial Services CO Portfolio

Follow Massachusetts Financial Services CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Massachusetts Financial Services CO , based on Form 13F filings with the SEC.

News

Stay updated on Massachusetts Financial Services CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email